Navigation Links
AMDL, Inc. Announces First Quarter 2009 Financial Results
Date:5/15/2009

TUSTIN, Calif., May 15 /PRNewswire-FirstCall/ -- AMDL, Inc. (NYSE Alternext US: ADL), a US-based pharmaceutical company with major operations in China, announced today unaudited results and the filing of its Form 10Q with the Securities and Exchange Commission ("SEC") for the first quarter ended March 31, 2009.

Financial Results

AMDL has a highly seasonal business that has historically resulted in low first quarter revenues and earnings. Given this seasonality, our first quarter results were within our expectations.

For the first quarter 2009 AMDL reported unaudited net revenues of approximately $2.71 million, a decrease of 7.8% compared with approximately $2.94 million in sales reported for the same period in FY2008. The decrease in net revenues was anticipated due to the seasonal nature of AMDL's business combined with the Company's inability to produce Goodnak(R) and Human Placenta Extract (HPE) anti-aging products dependent on a non-operational small-injectable production line which was off-line while awaiting mandatory 5-year GMP re-certification from the sFDA. In addition, distribution contracts with four primary beauty distributors expired during the fourth quarter of FY2008, impacting sales of other HPE-based anti-aging solutions. AMDL manufactured additional Goodnak and other small-injectable line dependant products in anticipation of these events and depleted product inventories sooner than anticipated due to higher than expected sales prior to year-end FY2008. The Company received re-certification on May 8, 2009 for the off-line small-injectable line and has resumed full product production. The Company is also in current re-negotiations to renew the expired distributor contracts pertaining to the HPE-based anti-aging solutions.

Gross profits for the first quarter FY2009 decreased to approximately $1.1 million compared to approximately $1.4 million for the same period in FY
'/>"/>

SOURCE AMDL, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine news :

1. AMDL, Inc. Selected as #1 Small-Cap Stock Pick for 2009
2. Rudd Report Gives AMDL, Inc. a Strong Buy Recommendation in Year-End Financial Research Report
3. AMDL, Inc. Completes Revision of Performance & Equity Incentive Compensation Plan
4. AMDL, Inc. Chairman & CEO Announces Expert Opinion on Chinas Economic Forecast
5. AMDL, Inc. Announces Final Closing of Private Placement of Senior Notes
6. AMDL, Inc. Issues Correction to January 30, 2009 Press Release Announcing Closing of Private Placement of Senior Notes
7. AMDL, Inc. to Present at 5th Annual Winter Technology Conference Hosted by Security Research Associates, Inc.
8. AMDL, Inc. Reports 2008 Year End Financial Results and Fiscal Year 2009 Financial Targets
9. AMDL, Inc. Enters Into Distribution Agreements With GenWay Biotech, Inc. to Advance Commercialization of the DR-70 (FDP) Cancer Test in the US and Canada
10. HHS Announces $75 Million in Supplemental Funding to States for Pandemic Flu Preparedness
11. CRC Health Group Announces Acquisition of Bayside Marin Recovery Center, San Rafael

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/7/2009)...ok (GA), Louis J. Goodman (TX), Palmer P. Jones (N...ov. 7 The American Medi... society executive leaders with achievement awards...als of the medical profession. The awards were pre...ing in Houston. ,, (Logo: http://www.newscom...
(Date:11/7/2009)...re/ -- The U.S. bishops November 7 urged members o...pak-Ellsworth Amendment to the health care reform....er-Lipinski-Smith Amendment will keep in place cur...e protections in the Affordable Health Care for Am...r was signed by Cardinal Justin Rigali, chair of t...
(Date:11/7/2009)...cross the U.S. , , SATURDAY, Nov. 7 (Healt... colleges do it regularly (and, it,s not sex). , R... alcoholic drinks at a sitting. , "People have a h...y Hwang, associate dean of students and director o...on Long Island, N.Y. In fact, she said, heavy drin...
(Date:11/6/2009)... /PRNewswire-FirstCall/ - Cardiome Pharma Corp. (N...will report financial results for the third quarte...y, November 9, 2009. Cardiome will hold a teleconf...Pacific) on that day to discuss the results. ,, To...806 or 888-789-9572 and reference conference 23452...
(Date:11/6/2009)... CNC ) today announced that it will present at tw...w weeks. ,, Next week, at the Credit Suisse 18th A...11-13, 2009, at the Arizona Biltmore Resort and Sp...mber 11th at 4:30 p.m. Mountain Time. Investors an...esentation at: http://w.on24.com/r.htm?e=174781&...
Breaking Medicine News(10 mins):Health News:AMA Honors Medical Society Executives 2Health News:Bishops Urge Passage of Stupak-Ellsworth Anti-Abortion Amendment for Health Reform Bill 2Health News:Binge Drinking Puts the Brain, and Life Itself, at Risk 2Health News:Binge Drinking Puts the Brain, and Life Itself, at Risk 3Health News:Cardiome to Release Third Quarter Results 2Health News:Cardiome to Release Third Quarter Results 3Health News:Centene Corporation to Present at Upcoming Healthcare Conferences 2
...s given the analysis, report says , MONDAY, Aug. 2...ic obstructive pulmonary disease (COPD) is not use...that found that only one-third of patients diagnos.... , "Without proper testing, both under-diagnosi...
...y researchers have first insight into how Huntingt...be published online in the British Journal, Human ...e are exciting results by the McMaster team, said ...he huntingtin protein has been known for almost 20...
...finds that implantable cardioverter defibrillators...r adults with left ventricular systolic dysfunctio...ized controlled trials that reported on mortality ...unction by 20 percent. This reduction came mostly ...
...7 Computer analysis of existing drugs may be key ...esistant pathogens like deadly tuberculosis strain...he use of such emergency discovery technology coul... Chemical Society. , Drug repurposing or reprofil...
... anthocyanin molecules could lead to new treatment...-- Compounds called anthocyanins, which give color...s, may help protect against colon cancer, an Ohio ...slow the growth of colon cancer cells. The team al...
...en that may be able to spot teens prone to violenc...- What motivates some teens to gun down fellow stu... , Perhaps a characteristic called "cynical shynes...ly, Virginia Tech, according to researchers who we...
Other Medicine News:Health News:A new molecular zip code, and a new drug target for Huntington's disease 2Health News:A new molecular zip code, and a new drug target for Huntington's disease 3Health News:Computers help chemists fight emerging infections 2Health News:Computers help chemists fight emerging infections 3Health News:Does Pathological Shyness Make for School Shooters? 2Health News:Does Pathological Shyness Make for School Shooters? 3Health News:Does Pathological Shyness Make for School Shooters? 4
(Date:11/6/2009).... 6 Boston Scientific Co...s reached an agreement in principle with the U.S. ...isories issued by its Guidant subsidiary in 2005. ...ior to Boston Scientific,s 2006 acquisition of Gui...osed an investigation by the U.S. Attorney,s Offic...
(Date:11/6/2009)...PRNewswire-FirstCall/ -- Keryx Biopharmaceuticals,... on Tuesday, November 10, 2009 at 8:30 a.m. EST to...and business outlook for the remainder of 2009. R..., will host the call. Keryx will announce its fin...to be issued prior to the call. ,, In order to ...
(Date:11/6/2009)...RNewswire-FirstCall/ -- Caraco Pharmaceutical Labo...orolac tromethamine ophthalmic solution, 0.5% foll...dministration (FDA) for Sun Pharma,s Abbreviated N...; opthalmic solution on the first day following pa...rapeutically equivalent to Acular® Ophthalmic...
Breaking Medicine Technology:Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 2Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 3Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 4Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 5Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 6Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 7Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 8Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 9Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 10Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 11Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 12Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 13Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 14Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 15Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 16Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 17Keryx Biopharmaceuticals, Inc. to Hold Conference Call on Third Quarter 2009 Financial Results on Tuesday, November 10, 2009 at 8:30 a.m. EST 2Caraco Pharmaceutical Laboratories, Ltd. Markets Generic Acular(R) Opthalmic Solution 22009 John M Eisenberg Patient Safety and Quality Award Recipients Announced 57801 12009 John M Eisenberg Patient Safety and Quality Award Recipients Announced 57801 22009 John M Eisenberg Patient Safety and Quality Award Recipients Announced 57801 32009 John M Eisenberg Patient Safety and Quality Award Recipients Announced 57801 4SC Johnson Joins Conservation Internationals Team Earth a Worldwide Sustainability Movement As One of the Founding Members 57799 1SC Johnson Joins Conservation Internationals Team Earth a Worldwide Sustainability Movement As One of the Founding Members 57799 2SC Johnson Joins Conservation Internationals Team Earth a Worldwide Sustainability Movement As One of the Founding Members 57799 3US Farms Inc Announces Membership to International Aloe Science Council Inc 57797 1US Farms Inc Announces Membership to International Aloe Science Council Inc 57797 2
...y prospectively planned 5-year study to show long ...t -, MONTREAL, Sept. 20 Bayer HealthCare Pharmac...NEFIT (BEtaseron in Newly Emerging,multiple sclero...y,initiation of Betaseron(R) (interferon beta-1b) ...e of multiple sclerosis (MS) significantly delayed...
...Novavax, Inc.,(Nasdaq: NVAX ) a clinical-stage va...hvi, President and Chief Executive Officer, will b...Conference in New York, NY. The,conference is bein...tel.,Dr. Singhvi will be presenting Thursday, Sept...hvi will provide an overview of the company,s,stra...
Other Medicine Technology:Five-Year Data Confirm That Early Treatment with Betaseron(R) at First Sign of Disease Can Delay Progression to MS 2Five-Year Data Confirm That Early Treatment with Betaseron(R) at First Sign of Disease Can Delay Progression to MS 3Five-Year Data Confirm That Early Treatment with Betaseron(R) at First Sign of Disease Can Delay Progression to MS 4Five-Year Data Confirm That Early Treatment with Betaseron(R) at First Sign of Disease Can Delay Progression to MS 5
Drug Facts - Silver (A to Z Drug Facts with Auto-Updates)
Drug Facts - Platinum (A to Z, Natural Products and Drug Interaction)
Drug Facts - Gold (A to Z Drugs and Drug Interaction)
... Guide to Drug Interaction Principles is the numbe...sly for clinicians. , An understanding of drug in... medicine. Since publication of the first edition ...macopoeia - coupled with prolonged human life span...
Medicine Products: